Invesco’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Buy |
82,142
+15,849
| +24% | +$151K | ﹤0.01% | 2952 |
|
|
2025
Q1 | $693K | Buy |
66,293
+25,970
| +64% | +$272K | ﹤0.01% | 3009 |
|
|
2024
Q4 | $950K | Sell |
40,323
-2,099
| -5% | -$49.5K | ﹤0.01% | 2930 |
|
|
2024
Q3 | $1.52M | Sell |
42,422
-217,432
| -84% | -$7.81M | ﹤0.01% | 2726 |
|
|
2024
Q2 | $9.17M | Buy |
259,854
+9,814
| +4% | +$346K | ﹤0.01% | 1839 |
|
|
2024
Q1 | $7.1M | Buy |
250,040
+174,868
| +233% | +$4.96M | ﹤0.01% | 2016 |
|
|
2023
Q4 | $1,000K | Sell |
75,172
-19,223
| -20% | -$256K | ﹤0.01% | 2884 |
|
|
2023
Q3 | $846K | Buy |
94,395
+25,354
| +37% | +$227K | ﹤0.01% | 2932 |
|
|
2023
Q2 | $777K | Sell |
69,041
-171,853
| -71% | -$1.93M | ﹤0.01% | 3003 |
|
|
2023
Q1 | $2.78M | Buy |
240,894
+106,116
| +79% | +$1.22M | ﹤0.01% | 2500 |
|
|
2022
Q4 | $1.56M | Sell |
134,778
-2,959
| -2% | -$34.3K | ﹤0.01% | 2722 |
|
|
2022
Q3 | $1.75M | Buy |
137,737
+126,391
| +1,114% | +$1.6M | ﹤0.01% | 2684 |
|
|
2022
Q2 | $78K | Sell |
11,346
-352
| -3% | -$2.42K | ﹤0.01% | 3898 |
|
|
2022
Q1 | $112K | Buy |
11,698
+292
| +3% | +$2.8K | ﹤0.01% | 3823 |
|
|
2021
Q4 | $136K | Sell |
11,406
-135
| -1% | -$1.61K | ﹤0.01% | 3818 |
|
|
2021
Q3 | $187K | Buy |
11,541
+1,587
| +16% | +$25.7K | ﹤0.01% | 3791 |
|
|
2021
Q2 | $209K | Buy |
+9,954
| New | +$209K | ﹤0.01% | 3744 |
|